Vincenzo Nibali says Chris Froome's salbutamol test result is 'not a great day for cycling'

Vuelta a España runner-up Vincenzo Nibali comments on the news that Chris Froome had higher-than-permitted levels of salbutamol in an anti-doping sample taken during the race

Chris Froome and Vincenzo Nibali during the 2017 Vuelta a España

(Image credit: Yuzuru Sunada)

Vincenzo Nibali has reacted to the news that Chris Froome returned an adverse analytical finding (AAF) for salbutamol during the 2017 Vuelta a España, saying that it is 'not a great day for cycling'.

Italian Nibali (Bahrain-Merida) finished as runner-up to overall winner Froome (Team Sky) at the end of the Vuelta a España in September.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Nigel Wynn
Former Associate Editor

Nigel Wynn worked as associate editor on, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.